PCSA
NSCProcessa Pharmaceuticals Inc.
Healthcare•Biotechnology
Watchlist:
Last updated: Friday 4th July 2025
0.19
+0.01 (3.34%)
Prev Close:0.1885
Open:0.19
Bid:0.1935
Ask:0.1957
52 Week Range
0.153.10
Volume:17,306,057
Mkt Cap:2 M
24
MarketXLS Rank ®
Weak Hold
Price Target
$0.22
+12.9%
Financials
Financial Statements
PCSA - Cash Flow (Annual)
| Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Impairment Charge | 7 M | 2 M | ||||||||
| Capital Expenditure Reported | 3244.0 | 2776.0 | 22282.0 | 20622.0 | 23775.0 | 1399.0 | ||||
| Cash Flow From Continuing Investing Activities | -3244.0 | -2776.0 | -22282.0 | 1 M | -1 M | 29701.0 | ||||
| Cash From Discontinued Operating Activities | 1197.0 | -371307.0 | ||||||||
| Change In Account Payable | 569263.0 | -15931.0 | 108643.0 | -101789.0 | 245082.0 | -216490.0 | 241416.0 | 9995.0 | 3707.0 | 5318.0 |
| Change In Accrued Expense | 432457.0 | -256787.0 | 243796.0 | -65049.0 | 93331.0 | 150432.0 | 122990.0 | -4136.0 | 75790.0 | 112014.0 |
| Change In Income Tax Payable | 100.0 | |||||||||
| Change In Interest Payable | 362.0 | 81894.0 | 150432.0 | 122990.0 | -4136.0 | 75790.0 | 112014.0 | |||
| Change In Payables And Accrued Expense | 1 M | -272718.0 | 352439.0 | -166838.0 | 338413.0 | -66058.0 | 364406.0 | 5859.0 | 79497.0 | 117432.0 |
| Change In Prepaid Assets | -1 M | 956834.0 | 210549.0 | -1 M | -239103.0 | -57773.0 | -216386.0 | -23299.0 | -16278.0 | 105136.0 |
| Change In Tax Payable | 100.0 | |||||||||
| Change In Working Capital | -28716.0 | 684116.0 | 633262.0 | -1 M | 22286.0 | -101932.0 | 188710.0 | -17440.0 | 57684.0 | 153500.0 |
| Common Stock Payments | -300000.0 | |||||||||
| Depreciation And Amortization | 782.0 | 222.0 | 904108.0 | 790972.0 | 803774.0 | 805556.0 | 697161.0 | 25235.0 | 1381.0 | 297623.0 |
| Financing Cash Flow | 8 M | 6 M | -388843.0 | 10 M | 18 M | 2 M | 3 M | 3 M | 4 M | 821098.0 |
| Gain Loss On Sale Of PPE | 25000.0 | 60743.0 | ||||||||
| Issuance Of Capital Stock | 10 M | 17 M | 3 M | 4 M | 88000.0 | |||||
| Issuance Of Debt | 162459.0 | 805000.0 | 3 M | 15000.0 | 733098.0 | |||||
| Net Business Purchase And Sale | 6280.0 | |||||||||
| Net Common Stock Issuance | -300000.0 | 10 M | 17 M | 3 M | 4 M | 88000.0 | ||||
| Net Intangibles Purchase And Sale | -1782.0 | |||||||||
| Net Investment Properties Purchase And Sale | -1782.0 | 1 M | -1 M | |||||||
| Net Investment Purchase And Sale | -1782.0 | 1 M | -1 M | |||||||
| Net Issuance Payments Of Debt | 162459.0 | 805000.0 | 3 M | 15000.0 | 733098.0 | |||||
| Net Long Term Debt Issuance | 805000.0 | 3 M | -19902.0 | |||||||
| Net PPE Purchase And Sale | -3244.0 | -2776.0 | -20622.0 | -23775.0 | 29701.0 | |||||
| Net Technology Purchase And Sale | -20500.0 | |||||||||
| Other Non-cash Items | 633010.0 | 2 M | 16 M | 4 M | 11 M | 432699.0 | 74063.0 | -33754.0 | -69379.0 | 2 M |
| Purchase Of Intangibles | -1782.0 | |||||||||
| Purchase Of Investment | 1 M | -1 M | ||||||||
| Purchase Of Long Term Investments | 1 M | -1 M | ||||||||
| Purchase Of PPE | -3244.0 | -2776.0 | -20622.0 | -23775.0 | -1399.0 | |||||
| Purchase Of Technology | -20500.0 | |||||||||
| Repayment Of Debt | -19902.0 | |||||||||
| Sale Of Investment | 1 M | |||||||||
| Sale Of PPE | 17000.0 | 31100.0 | ||||||||
| Short Term Debt Issuance | 162459.0 | 3 M | 15000.0 | 753000.0 | ||||||
| Stock Based Compensation | 629514.0 | 2 M | 9 M | 3 M | 3 M | 510478.0 | 74063.0 | 6691.0 | 96929.0 | |
| Amord | 788495.0 | 790488.0 | 995228.0 | 795328.0 | 688716.0 | 23370.0 | 967.0 | 178571.0 | ||
| Begcash | 16 M | 15 M | 691536.0 | 2 M | 3 M | 1 M | 14440.0 | 25044.0 | ||
| Capex | -3244.0 | -2776.0 | -1782.0 | -20622.0 | -23775.0 | 29701.0 | ||||
| Cffcf | 8 M | 6 M | -388843.0 | 10 M | 18 M | 2 M | 3 M | 3 M | 4 M | 821098.0 |
| Cffdi | 10503.0 | |||||||||
| Cffinv | -3244.0 | -2776.0 | -22282.0 | 1 M | -1 M | 40204.0 | ||||
| Cffoa | -11 M | -8 M | -10 M | -9 M | -3 M | -3 M | -4 M | -2 M | -2 M | -4 M |
| Chgcash | -4 M | -2 M | -10 M | 1 M | 15 M | -1 M | -1 M | 2 M | 1 M | -4 M |
| Chginv | -7065.0 | |||||||||
| Chgothcl | -5535.0 | -58165.0 | ||||||||
| Chgpay | 569263.0 | -15931.0 | 108643.0 | -101789.0 | 245082.0 | -216490.0 | 241416.0 | 9995.0 | 3707.0 | 5418.0 |
| Chgrec | 70274.0 | 6750.0 | -77024.0 | 21899.0 | 40690.0 | -3838.0 | ||||
| Comstkiss | 10 M | 17 M | 3 M | 4 M | 88000.0 | |||||
| Definc | -530611.0 | -1 M | -602716.0 | -902801.0 | -166787.0 | |||||
| Deftax | -530611.0 | -1 M | -602716.0 | -902801.0 | -166787.0 | |||||
| Depamor | 782.0 | 222.0 | 904108.0 | 790972.0 | 8446.0 | 805556.0 | 8445.0 | 1865.0 | 1381.0 | 297623.0 |
| Endcash | -11 M | -8 M | 7 M | 16 M | 15 M | -1 M | 2 M | 3 M | 1 M | -3 M |
| Fcf | -11 M | -8 M | -10 M | -9 M | -3 M | -3 M | -4 M | -2 M | -2 M | -4 M |
| Ltdebtiss | 805000.0 | 3 M | ||||||||
| Ltdebtpay | -19902.0 | |||||||||
| Netinccont | -12 M | -11 M | -27 M | -11 M | -14 M | -3 M | -4 M | -2 M | -2 M | -6 M |
| Netothfin | -88843.0 | -250889.0 | 604788.0 | 900000.0 | -168457.0 | 227657.0 | -227657.0 | |||
| Netothinv | -1782.0 | 6280.0 | ||||||||
| Netstdebtiss | 162459.0 | 3 M | 15000.0 | 753000.0 | ||||||
| Opcf | -11 M | -8 M | -10 M | -9 M | -3 M | -3 M | -4 M | -2 M | -2 M | -4 M |
| Opgainloss | 81530.0 | 85518.0 | 84377.0 | 78288.0 | 74124.0 | 29731.0 | 60743.0 | |||
| Purchbus | 6280.0 | |||||||||
| Repurchstk | -300000.0 | |||||||||
| Salesti | 1 M |
Call: 1-877-778-8358 
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.
I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.
I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...
MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.
I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.